2025-520790-39-00RecruitingPhase 1
CLonE-specific CAR T-Cell therapy in relapsed or refractory AL amyloidosis - a single-center Phase I trial (CLEAR AL)
Universitaetsklinikum Heidelberg AöR1 site in 1 country7 target enrollmentStarted: November 25, 2025Last updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Enrollment
- 7
- Locations
- 1
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 65+ years (18-64 Years, 65+ Years)
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Prof. Dr. med. Stefan Schönland
Scientific
Universitaetsklinikum Heidelberg AöR
Study Sites (1)
Loading locations...
Similar Trials
Active, not recruiting
Phase 1
A trial to test CAR-T cells for glioblastoma in adults when standard treatment is not effective or stops workingRelapsed/refractory glioblastomaCancerISRCTN22366199niversity College London12
Recruiting
Phase 2
A clinical trial to learn about the effects of YTB323 in people with difficult to treat severe diffuse cutaneous systemic sclerosis (dcSSc)2023-510380-34-00Novartis Pharma AG72
Active, not recruiting
Phase 1
Study of genetically modified patient immune cells in treatment of refractory leukemia and lymphoma of B-cell origiAcute Lymphoblastic Leukemia and B-cell Non Hodgkin LymphomaMedDRA version: 21.1Level: LLTClassification code 10066109Term: Precursor B-lymphoblastic leukemia acuteSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10012855Term: Diffuse large cell lymphoma (Diffuse large B-cell lymphoma) (Working Formulation)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10060669Term: B-cell chronic lymphocytic leukemia/prolymphocytic leukemia/small lymphocytic lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: HLTClassification code 10036524Term: Precursor B-lymphoblastic lymphomasSystem Organ Class: 100000004851MedDRA version: 20.0Level: HLTClassification code 10026798Term: Mantle cell lymphomasSystem Organ Class: 100000004851MedDRA version: 20.0Level: HLTClassification code 10020068Term: High grade B-cell lymphomas Burkitt-like lymphomaSystem Organ Class: 100000004851MedDRA version: 20.0Level: HLTClassification code 10036711Term: Primary mediastinal large B-cell lymphomasSystem Organ Class: 100000004851MedDRA version: 24.0Level: PTClassification code 10085128Term: Follicular lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-006556-14-DKRigshospitalet20
Not yet recruiting
Phase 1
CAR-T for Claudin18.2 Positive Solid TumorsNCT07266311Chengdu Ucello Biotechnology Co., Ltd.18
Recruiting
Phase 1
A Phase I Clinical Trial of CART cell therapy for refractory/ relapsed acute lymphoblastic leukemia with unmet needs in children, adolescents and young adults: feasibility and safety study (REALL_CART)2023-509723-41-01Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz10